%0 Journal Article
%T Necrotizing Enterocolitis following Onasemnogene Abeparvovec for Spinal Muscular Atrophy: A Case Series.
%A Gaillard J
%A Gu AR
%A Neil Knierbein EE
%J J Pediatr
%V 260
%N 0
%D 2023 09 19
%M 37211209
%F 6.314
%R 10.1016/j.jpeds.2023.113493
%X Onasemnogene abeparvovec treats spinal muscular atrophy by delivering a functional SMN1 gene. Necrotizing enterocolitis typically occurs in preterm infants. We report 2 term infants diagnosed with spinal muscular atrophy who presented with necrotizing enterocolitis after onasemnogene abeparvovec infusion. We discuss potential etiologies and propose monitoring for necrotizing enterocolitis after onasemnogene abeparvovec therapy.